Innotox 50U: The Ready-to-Use Líquido Botox — Clinical Guide

Innotox 50U by Medytox represents a genuine innovation in botulinum toxin administration. As the only widely available liquid (non-lyophilised) botulinum toxin type A, Innotox eliminates the reconstitution step entirely — reducing preparation time, minimising dilution error risk, and streamlining the clinical workflow for busy aesthetic practices.

What Makes Innotox Different

All other major botulinum toxin products on the market — including Botulax, Nabota, Liztox, Metox, and Botox — are supplied as lyophilised (freeze-dried) powders. Before use, they must be reconstituted with preservative-free saline, a process that takes 5–10 minutes and introduces variability if the technique or volume is inconsistent.

Innotox is fundamentally different. It is manufactured as a stable liquid preparation, available ready to inject at 4 units per 0.1 ml. There is no reconstitution, no diluent to prepare, and no variation in concentration between practitioners or sessions.

Clinical Advantages of Líquido Formaaulation

How to Use Innotox 50U

1. 1
   Temperature preparationRemove from refrigerator. Optional: allow 5 minutes to equilibrate. Não reconstitution needed.
2. 2
   Prepare the frascoClean stopper with alcohol swab. Allow to dry.
3. 3
   Draw the doseInsert 30–32G needle into frasco. Aspirate the required volume at 4 U/0.1 ml. For glabellar (25 U): 0.625 ml. For forehead (15 U): 0.375 ml. For crow's feet per side (12 U): 0.3 ml.
4. 4
   Confirm volumeCheck syringe markings. Concentration is always 4 U/0.1 ml — straightforward calculation.
5. 5
   InjectStandard injection technique. Same points and depths as lyophilised toxins.
6. 6
   ConservaçãoReturn capped frasco to refrigerator. Use remaining within same session.

Dosing Reference for Innotox 50U

Comparison: Innotox 50U vs Lyophilised Toxins

For practitioners currently using Botulax 100U, Nabota 100U, or other lyophilised products, switching to Innotox for appropriate treatment scenarios offers significant workflow benefits. The fixed concentration eliminates one variable in clinical outcomes, and the ready-to-use format is particularly valued in high-volume settings.

The 50-unit frasco size means Innotox is typically used for single-patient sessions focusing on 1–3 treatment areas, while 100-unit lyophilised frascos offer more flexibility for multi-area or multi-patient use. Many practitioners keep both in their refrigerator, using Innotox for convenience when speed matters and lyophilised products for larger treatment sessions.